Healthcare & Pharma

With one of the vast network of life sciences professionals and clientele ranging from research scientists to pharmaceutical companies and hospitals, Areness led by one of its top management hailing from a biomedicine background has a keen affinity towards this sector. Patents to licensing, protection from regulatory action to international trade, we provide end to end support to the said sector.

Understanding the demands of the sector, we guide through the process of mandatory approvals from various statutory authorities and also protect the intellectual property globally. We also assist in licensing, leasing, labelling and other compliances. We guide our clients through reporting of new guidelines, taking safety measures to avoid regulatory action and work with intermediaries for extensive coverage.


COVID-19 inducedamendments in the Insolvency & Bankruptcy Code: An endeavour to de-stress the distressed Companies

Read More

Careers in Intellectual Property Law: The Emerging Dimension of Law

Read More


Read More

Research and Insights

Balance Sheets As ‘acknowledgement Of Debt’: End Of Long Drawn Confusion

The Insolvency and Bankruptcy Code, 2016 (‘Code’) was incorporated with the aim to facilitate speedy debt resolution process and balance of interest of the all the stakeholders.


Extinguishment of prior criminal liabilities of a Corporate Debtor: A safety armour for Resolution Applicants

The jurisprudence developing around the Insolvency & Bankruptcy Code, 2016 (hereinafter referred to as ‘I & B Code’) is, nowadays, focused on affording protection


Cross Border Insolvency under the I & B Code, 2016: The road ahead

Law relating to cross border insolvency concerns itself with Indian financial creditors having claims upon defaulting companies which are global, or global financial persons having claims

Area Of Practice

Other Practice Areas